Amedeo Smart

Free Medical Literature Service

 

Amedeo

Malignant Lymphoma
  Free Subscription

Articles published in
Br J Dermatol
    September 2025
  1. HODAK E, Amitay-Laish I, Bagot M, Battistella M, et al
    ISCL/EORTC-CLTG/USCLC recommendations for the diagnosis, staging and treatment of early-stage paediatric mycosis fungoides: a modified Delphi consensus. Part two: treatment.
    Br J Dermatol. 2025;193:653-661.
    >> Share

  2. GHOSH S, Pavlova O, Latshaw A, Kim D, et al
    Multi-Harmonic Imaging-Based Automated Recognition of Cutaneous T-Cell Lymphoma.
    Br J Dermatol. 2025 Sep 4:ljaf345. doi: 10.1093.
    >> Share

    August 2025
  3. HODAK E, Amitay-Laish I, Bagot M, Battistella M, et al
    ISCL/EORTC-CLTG/USCLC recommendations for the diagnosis, staging and treatment of early-stage paediatric mycosis fungoides: a modified Delphi consensus. Part one: diagnosis and staging.
    Br J Dermatol. 2025;193:405-414.
    >> Share

    June 2025
  4. IVERT LU, Ekberg S, Smedby KE, Brauner H, et al
    Increased mortality due to lymphoma and infections in patients with mycosis fungoides or Sezary syndrome: A Swedish nationwide, population-based cohort study.
    Br J Dermatol. 2025 Jun 19:ljaf233. doi: 10.1093.
    >> Share

    May 2025
  5. DOELEMAN T, Beljaards ESM, Ottevanger R, Jansen P, et al
    Added value of pathology consultations in cutaneous lymphomas: a 2-year review from the Dutch national referral and expertise centre.
    Br J Dermatol. 2025 May 14:ljaf184. doi: 10.1093.
    >> Share

    April 2025
  6. PILERI A, Zengarini C
    Harnessing Extracorporeal Photopheresis to Trigger Immunogen Cell Death: A Bounty on Cutaneous Lymphoma Cells.
    Br J Dermatol. 2025 Apr 12:ljaf138. doi: 10.1093.
    >> Share

    March 2025
  7. BAGOT M
    Therapeutic advances for Cutaneous T Cell Lymphoma.
    Br J Dermatol. 2025 Mar 22:ljaf105. doi: 10.1093.
    >> Share

  8. LACKNER A, Burner T, Brandner M, Dey S, et al
    Evidence of Immunogenic Cell Death (ICD) and ICD-dependent Dendritic Cell Activation Induced by Extracorporeal Photopheresis in Patients with leukemic forms of cutaneous T cell lymphoma.
    Br J Dermatol. 2025 Mar 20:ljaf102. doi: 10.1093.
    >> Share

    February 2025
  9. COSTANZA M, Giordano C, von Brunneck AC, Zhao J, et al
    Preclinical in vitro and in vivo evidence for CD74-targeting as effective treatment strategy for cutaneous T cell lymphomas.
    Br J Dermatol. 2025 Feb 27:ljaf001. doi: 10.1093.
    >> Share

  10. OTTEVANGER R, Vermeer MH
    Cutaneous T-cell lymphoma in Australia: what drives geospatial?
    Br J Dermatol. 2025 Feb 22:ljaf026. doi: 10.1093.
    >> Share

  11. GNIADECKI R, Guenova E, Querfeld C, Nicolay JP, et al
    Haematogenous seeding in mycosis fungoides and Sezary syndrome: current evidence and clinical implications.
    Br J Dermatol. 2025;192:381-389.
    >> Share

  12. WEHKAMP U, Pietzka S, Kotrova M, Jost M, et al
    Mycosis fungoides: differentiation from inflammation and detection of circulating tumour cells with the EuroClonality next-generation sequencing assay.
    Br J Dermatol. 2025;192:492-500.
    >> Share

    January 2025
  13. GNIADECKI R
    Chaperoning a Cure: Unexpected Role of CD74 in Cutaneous T-cell lymphoma.
    Br J Dermatol. 2025 Jan 29:ljaf040. doi: 10.1093.
    >> Share

    December 2024
  14. BONTOUX C, Badrignans M, Afach S, Sbidian E, et al
    Pustular mycosis fungoides has a poor outcome: a multicentric clinicopathological and molecular case series.
    Br J Dermatol. 2024;192:125-134.
    >> Share

  15. CAMPBELL BA, Baade PD, Dasgupta P, Cameron JK, et al
    Geospatial analyses demonstrate variation of cutaneous T-cell lymphomas across Australia, providing insights into possible causes.
    Br J Dermatol. 2024 Dec 6:ljae476. doi: 10.1093.
    >> Share

    October 2024
  16. BLANCHARD G, Atallah I, Blanchard M, Fehrenbacher B, et al
    Primary cutaneous T-cell lymphoma not otherwise specified (NOS) uncovering a novel RAB27A variant in Griscelli syndrome type 2.
    Br J Dermatol. 2024 Oct 21:ljae412. doi: 10.1093.
    >> Share

    September 2024
  17. TENSEN CP, Vermeer MH
    Single cell analyses of cutaneous T-cell lymphoma biopsies.
    Br J Dermatol. 2024 Sep 13:ljae351. doi: 10.1093.
    >> Share

    August 2024
  18. STADLER R
    The interferon story continues: EORTC CLTG study explores pegylated interferon alpha-2a's role in treating mycosis fungoides/Sezary syndrome.
    Br J Dermatol. 2024;191:321-322.
    >> Share

  19. MITSUNAGA K, Bagot M, Ram-Wolff C, Guenova E, et al
    Real-world study of pegylated interferon alpha-2a to treat mycosis fungoides/Sezary syndrome using time to next treatment as a measure of clinical benefit: an EORTC CLTG study.
    Br J Dermatol. 2024;191:419-427.
    >> Share

  20. CHENNAREDDY S, Rindler K, Ruggiero JR, Alkon N, et al
    Single-cell RNA sequencing comparison of CD4+, CD8+ and TCR-gammadelta+ cutaneous T-cell lymphomas reveals subset-specific molecular phenotypes.
    Br J Dermatol. 2024 Aug 12:ljae313. doi: 10.1093.
    >> Share

    July 2024
  21. RAYMUNDO C, Cella D, Wagner L, Hippe DS, et al
    Development and psychometric properties of the Functional Assessment of Cancer Therapy-Cutaneous T-Cell Lymphoma (FACT-CTCL).
    Br J Dermatol. 2024 Jul 30:ljae308. doi: 10.1093.
    >> Share

  22. BATTISTELLA M
    Paediatric lymphomatoid papulosis: a benign clonal T-cell disorder that is a harbinger of haematological malignancy.
    Br J Dermatol. 2024;191:158-159.
    >> Share

    June 2024
  23. WOBSE M, Appenzeller S, Roth S, Siedel C, et al
    Oncogenic alterations in KIR3DL1 in cutaneous acral CD8+ lymphoproliferative disorder.
    Br J Dermatol. 2024 Jun 27:ljae256. doi: 10.1093.
    >> Share

  24. TZOUMPA S, Ingen-Housz-Oro S, de Masson A, Pham-Ledard A, et al
    Evolution of patients with Sezary syndrome after mogamulizumab discontinuation for any cause except progression: a multicentre retrospective study (Moga-stop Study).
    Br J Dermatol. 2024;191:143-144.
    >> Share

    May 2024
  25. JAMES M, Nakamura M, Whittaker S, Morris S, et al
    Mycosis fungoides: successful re-treatment with brentuximab vedotin.
    Br J Dermatol. 2024;190:929-930.
    >> Share

  26. RODRIGUEZ M, Rebollo-Gonzalez M, Frutos Diaz-Alejo J, Manso R, et al
    Mutational profiling of Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders do not resemble nodal peripheral T-cell lymphomas with follicular helper T-cell phenotype.
    Br J Dermatol. 2024 May 13:ljae192. doi: 10.1093.
    >> Share

    April 2024
  27. BLANCHARD M, Morren MA, Busschots AM, Hauben E, et al
    Paediatric onset lymphomatoid papulosis: results of a multicentre retrospective cohort study, on behalf of the EORTC Cutaneous Lymphoma Tumours Group (CLTG).
    Br J Dermatol. 2024 Apr 10:ljae150. doi: 10.1093.
    >> Share

  28. ROCCUZZO G, Calvao J, Dobos G, Morsia E, et al
    Cutaneous T-cell lymphoma care across Europe: insights from the Horizon Project.
    Br J Dermatol. 2024 Apr 5:ljae145. doi: 10.1093.
    >> Share

    February 2024
  29. STAMMLER R, Ta VA, Cohen E, Ram-Wolff C, et al
    Failure of second challenge with Mogamulizumab in CCR4-positive cutaneous T-cell lymphoma.
    Br J Dermatol. 2024 Feb 23:ljae085. doi: 10.1093.
    >> Share

  30. JUNG JM, Cho HS, Kim GH, Won CH, et al
    Psoriasiform mycosis fungoides: a clinical and prognostic retrospective cohort study.
    Br J Dermatol. 2024;190:432-434.
    >> Share

    January 2024
  31. TRUM NA, Chen L, Zain J, Rosen ST, et al
    Significant survival disparity in Black patients with cutaneous lymphoma: a retrospective cohort study.
    Br J Dermatol. 2024 Jan 29:ljae039. doi: 10.1093.
    >> Share

    October 2023

  32. Multiple skin lesions, especially on the legs, predict a poorer prognosis in skin lymphoma with large tumour cells.
    Br J Dermatol. 2023;189:e98.
    >> Share


  33. The effect of extracorporeal photopheresis on cytokines released by leukaemic cutaneous T-cell lymphoma.
    Br J Dermatol. 2023;189:e97.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016